Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has entered into a definitive agreement to sell its Extremity Orthopedics business to Smith+Nephew (LSE:SN, NYSE:SNN) for $240 million in cash. The transaction is expected to close at or around the end of 2020, subject to the satisfaction of customary conditions including regulatory approvals and consultation with employee representative bodies. “Smith+Nephew’s strong focus in orthopedics will enable the business to expand its reach and scale, while allowing the team to thrive in a new environment,” said Peter Arduini, president and CEO, Integra LifeSciences.
Read the full article: Integra LifeSciences Announces Definitive Agreement to Divest Its Extremity Orthopedics Business to Smith+Nephew for $240M //
Source: https://www.globenewswire.com/news-release/2020/09/29/2100557/0/en/Integra-LifeSciences-Announces-Definitive-Agreement-to-Divest-its-Extremity-Orthopedics-Business-to-Smith-Nephew-for-240-Million.html